US Broker Ratings

CVS Health Corporation (CVS): Investor Outlook and Growth Potential Amidst Healthcare Sector Dynamics

CVS Health Corporation (NYSE: CVS), a stalwart in the healthcare sector, is drawing investor attention with its robust market presence and diversified service offerings. With a market capitalization of $104.66..

Nuvalent, Inc. (NUVL) Stock Analysis: Unpacking a 27% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NUVL), a dynamic player in the biotechnology industry, has been making waves with its promising pipeline in the cancer treatment domain. With a market capitalization of $6.67 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating High Growth and Strategic Collaborations in Healthcare Tech

In the rapidly evolving landscape of healthcare technology, Tempus AI, Inc. (NASDAQ: TEM) is carving a niche with its robust suite of data-driven solutions and strategic collaborations. As a leading..

Medpace Holdings, Inc. (MEDP) Stock Analysis: An Insight into Growth and Valuation Amidst Mixed Analyst Ratings

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $14.84 billion, Medpace..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unpacking a 21% Upside Potential Amidst Solid Revenue Growth

Investors with an eye on the healthcare sector might find Neurocrine Biosciences, Inc. (NASDAQ: NBIX) particularly compelling, given its promising 21.12% upside potential. This San Diego-based company, which operates in..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 20% Potential Upside for Investors

As a cornerstone of the healthcare sector, Merck & Company, Inc. (NYSE: MRK) stands out in the pharmaceutical industry with a robust array of products and a rich history dating..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: 18% Potential Upside Beckons Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) stands out in the healthcare sector, not only for its innovative contributions to health information services but also for its promising stock trajectory. With..

Qiagen N.V. (QGEN) Stock Analysis: Potential Upside and Robust Revenue Growth in the Diagnostics & Research Sector

Qiagen N.V. (NYSE: QGEN) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Venlo, the Netherlands, the company has carved out..

Waystar Holding Corp. (WAY) Stock Analysis: Unpacking a 34.70% Potential Upside in Health Information Services

Waystar Holding Corp. (WAY), a notable player in the health information services sector, is sparking interest among investors with a promising potential upside of 34.70%. This Lehi, Utah-based company, established..

Revolution Medicines, Inc. (RVMD) Investor Outlook: A Bold 41% Upside Potential in Precision Oncology

Investors seeking opportunities in the high-stakes world of biotechnology should take note of Revolution Medicines, Inc. (NASDAQ: RVMD), a company at the forefront of developing targeted therapies for RAS-addicted cancers...

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth Amidst a 16.28% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, stands at a pivotal juncture for investors as it navigates the competitive landscape of medical distribution. With a market..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a 17% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN) is emerging as a compelling opportunity within the healthcare sector, particularly for investors keen on the medical instruments and supplies industry. With a market cap..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Healthcare Sector Dynamics with a 14.61 Forward P/E

For investors eyeing the healthcare sector, Avantor, Inc. (AVTR) presents a compelling case with its expansive reach and diverse portfolio in the medical instruments and supplies industry. Headquartered in Radnor,..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 16.76% Potential Upside Amidst Market Challenges

Investors eyeing the healthcare sector may find Viatris Inc. (VTRS) an intriguing prospect, especially with its potential upside of 16.76%. Despite some challenges, Viatris, a key player in the specialty..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Royalty Landscape

Royalty Pharma plc (NASDAQ: RPRX) offers a unique investment opportunity within the biotechnology sector, specifically focusing on biopharmaceutical royalties. With a market capitalization of $21.58 billion, this New York-based company..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 33% Potential Upside in the Healthcare Sector

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the health information services industry, is catching the eye of investors with a compelling potential upside of 33.16%. As a pivotal part..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Growth with a 2.69% Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor interest with its robust market presence and solid financial performance. With a market capitalization of..

Repligen Corporation (RGEN) Stock Analysis: Exploring a Promising 18.17% Upside Potential

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, is catching the eye of investors with its robust 18.17% potential upside, as indicated by the average analyst target..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Market Volatility with a 16.83% Upside Potential

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has been a focal point for investors seeking exposure to genetic and..

Tenet Healthcare Corporation (THC): Stock Analysis Reveals 5.64% Potential Upside and Strong Buy Consensus

Tenet Healthcare Corporation (NYSE: THC) is making waves in the healthcare sector, boasting a market capitalization of $17.67 billion and a robust operational framework. With a presence across the United..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds